[LXRX] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
01-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -11.96%
YoY- -12.14%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 20,089 376 676 214 199 555 1,233 59.15%
PBT -38,112 -28,074 -26,028 -29,080 -25,459 -25,896 -25,193 7.13%
Tax 1,638 1,655 435 -333 -643 712 1,119 6.55%
NP -38,112 -28,074 -26,028 -29,080 -25,931 -26,638 -25,193 7.13%
Tax Rate - - - - - - - -
Total Cost 58,201 28,450 26,704 29,294 26,130 27,193 26,426 14.05%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin -189.72 -7,466.49 -3,850.30 -13,588.79 -13,030.65 -4,799.64 -2,043.23 -32.68%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
EPS -0.37 -0.27 -0.35 -0.40 -0.38 -0.55 -0.52 -5.50%
EPS Diluted -0.37 -0.27 -0.35 -0.40 -0.38 -0.55 -0.52 -5.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.